Skip to main content
Top
Published in: BMC Anesthesiology 1/2018

Open Access 01-12-2018 | Research article

Association between troponin-I levels and outcome in critically ill patients admitted to non-cardiac intensive care unit with high prevalence of cardiovascular risk factors

Authors: Abdulaleem Alatassi, Mohamad Habbal, Hani Tamim, Musharaf Sadat, Eman Al Qasim, Yaseen M. Arabi

Published in: BMC Anesthesiology | Issue 1/2018

Login to get access

Abstract

Background

The association of troponin-I levels and outcome in medical-surgical ICU patients has been studied before in populations with low to moderate prevalence of cardiovascular risk factors. The objective in this article is to examine the association of troponin-I levels with hospital mortality in patients with high prevalence of cardiovascular risk factors who were admitted with medical-surgical indications to a non-cardiac intensive care unit.

Methods

This was a retrospective study of adult patients admitted to a tertiary medical-surgical ICU between July 2001 and November 2011. Data were extracted from prospectively collected ICU and clinical laboratory databases. Patients were stratified based on the highest troponin-I level in the first 72 h of admission into four groups (Group I < 0.03, Group II = 0.03–0.3, Group III = 0.3–3 and Group IV > 3 ng/mL). Hospital mortality was the primary outcome. To study the association between elevated troponin-I and hospital mortality, we carried out multivariate logistic regression analyses with Group I as a reference group.

Results

During the study period, 3368 patients had troponin-I levels measured in the first 72 h, of whom 1293 (38.3%) were diabetic and 1356 (40.2%) were chronically hypertensive. Among the study population, 2719 (81%) had elevated troponin-I levels (0.03 ng/mL and higher). Hospital mortality increased steadily as the troponin-I levels increased. Hospital mortality was 23.4% for Group I, 33.2% for Group II (adjusted odds ratio (aOR) 1.08, 95% confidence interval (CI) 0.84, 1.38), 49.6% for Group III (aOR = 1.64, 95% CI 1.24, 2.17), and 57.4% for Group IV (aOR 1.80, 95% CI 1.30, 2.49). The association of increased mortality with increased troponin level was observed whether patients had underlying advanced heart failure or not. Subgroup analysis showed an increased mortality in patients aged < 50 years, non-diabetics and not on vasopressors.

Conclusion

In a population with high prevalence of diabetes and hypertension, elevated troponin-I was frequently observed in medical-surgical critically ill patients, and showed a level-dependent association with hospital mortality.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hjortshoj S, Dethlefsen C, Kristensen SR, et al. Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers. Scand J Clin Lab Invest. 2008;68(2):130–3.CrossRefPubMed Hjortshoj S, Dethlefsen C, Kristensen SR, et al. Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers. Scand J Clin Lab Invest. 2008;68(2):130–3.CrossRefPubMed
3.
go back to reference Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined--a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959–69.CrossRefPubMed Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined--a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959–69.CrossRefPubMed
4.
go back to reference Noveanu M, Mebazaa A, Mueller C. Cardiovascular biomarkers in the ICU. Curr Opin Crit Care. 2009;15(5):377–83.CrossRefPubMed Noveanu M, Mebazaa A, Mueller C. Cardiovascular biomarkers in the ICU. Curr Opin Crit Care. 2009;15(5):377–83.CrossRefPubMed
6.
go back to reference Heidenreich PA, Alloggiamento T, Melsop K, et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001;38(2):478–85.CrossRefPubMed Heidenreich PA, Alloggiamento T, Melsop K, et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001;38(2):478–85.CrossRefPubMed
7.
go back to reference Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335(18):1342–9.CrossRefPubMed Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335(18):1342–9.CrossRefPubMed
8.
go back to reference Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA investigators. N Engl J Med. 1996;335(18):1333–41.CrossRefPubMed Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA investigators. N Engl J Med. 1996;335(18):1333–41.CrossRefPubMed
9.
go back to reference Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005;142(9):786–91.CrossRefPubMed Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005;142(9):786–91.CrossRefPubMed
10.
go back to reference Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.CrossRefPubMed Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.CrossRefPubMed
11.
go back to reference Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423.CrossRefPubMedPubMedCentral Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423.CrossRefPubMedPubMedCentral
12.
go back to reference El Bcheraoui C, Memish ZA, Tuffaha M, et al. Hypertension and its associated risk factors in the Kingdom of Saudi Arabia, 2013: a National Survey. Int J Hypertens. 2014;2014:8.CrossRef El Bcheraoui C, Memish ZA, Tuffaha M, et al. Hypertension and its associated risk factors in the Kingdom of Saudi Arabia, 2013: a National Survey. Int J Hypertens. 2014;2014:8.CrossRef
13.
go back to reference Lim W, Qushmaq I, Devereaux PJ, et al. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med. 2006;166(22):2446–54.CrossRefPubMed Lim W, Qushmaq I, Devereaux PJ, et al. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med. 2006;166(22):2446–54.CrossRefPubMed
14.
go back to reference Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–29.CrossRefPubMed Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–29.CrossRefPubMed
15.
go back to reference Lemeshow S, Teres D, Klar J, et al. Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. JAMA. 1993;270(20):2478–86.CrossRefPubMed Lemeshow S, Teres D, Klar J, et al. Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. JAMA. 1993;270(20):2478–86.CrossRefPubMed
16.
go back to reference Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-up. Diabetologia. 1996;39(12):1577–83.CrossRefPubMed Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-up. Diabetologia. 1996;39(12):1577–83.CrossRefPubMed
17.
go back to reference King DA, Codish S, Novack V, et al. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care. 2005;9(4):R390.CrossRefPubMedPubMedCentral King DA, Codish S, Novack V, et al. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care. 2005;9(4):R390.CrossRefPubMedPubMedCentral
18.
go back to reference Wu TT, Yuan A, Chen CY, et al. Cardiac troponin I levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the APACHE II score in outcome prediction. Shock (Augusta, Ga). 2004;22(2):95–101.CrossRef Wu TT, Yuan A, Chen CY, et al. Cardiac troponin I levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the APACHE II score in outcome prediction. Shock (Augusta, Ga). 2004;22(2):95–101.CrossRef
19.
go back to reference Baillard C, Boussarsar M, Fosse J-P, et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med. 2003;29(4):584–9.CrossRefPubMed Baillard C, Boussarsar M, Fosse J-P, et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med. 2003;29(4):584–9.CrossRefPubMed
20.
go back to reference Arlati S, Brenna S, Prencipe L, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med. 2000;26:31–7.CrossRefPubMed Arlati S, Brenna S, Prencipe L, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med. 2000;26:31–7.CrossRefPubMed
21.
go back to reference ver Elst KM, Spapen HD, Nguyen DN, et al. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem. 2000;46(5):650–7.PubMed ver Elst KM, Spapen HD, Nguyen DN, et al. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem. 2000;46(5):650–7.PubMed
22.
go back to reference Landesberg G, Vesselov Y, Einav S, et al. Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med. 2005;33(6):1281–7.CrossRefPubMed Landesberg G, Vesselov Y, Einav S, et al. Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med. 2005;33(6):1281–7.CrossRefPubMed
23.
go back to reference Mehta NJ, Khan IA, Gupta V, et al. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol. 2004;95(1):13–7.CrossRefPubMed Mehta NJ, Khan IA, Gupta V, et al. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol. 2004;95(1):13–7.CrossRefPubMed
24.
go back to reference Webb IG, Yam ST, Cooke R, et al. Elevated baseline cardiac troponin levels in the elderly - another variable to consider? Heart Lung Circ. 2015;24(2):142–8.CrossRefPubMed Webb IG, Yam ST, Cooke R, et al. Elevated baseline cardiac troponin levels in the elderly - another variable to consider? Heart Lung Circ. 2015;24(2):142–8.CrossRefPubMed
25.
go back to reference Tiruvoipati R, Sultana N, Lewis D. Cardiac troponin I does not independently predict mortality in critically ill patients with severe sepsis. Emerg Med Australas. 2012;24(2):151–8.CrossRefPubMed Tiruvoipati R, Sultana N, Lewis D. Cardiac troponin I does not independently predict mortality in critically ill patients with severe sepsis. Emerg Med Australas. 2012;24(2):151–8.CrossRefPubMed
26.
go back to reference Lim W, Whitlock R, Khera V, et al. Etiology of troponin elevation in critically ill patients. J Crit Care. 2010;25(2):322–8.CrossRefPubMed Lim W, Whitlock R, Khera V, et al. Etiology of troponin elevation in critically ill patients. J Crit Care. 2010;25(2):322–8.CrossRefPubMed
27.
go back to reference Poe S, Vandivier-Pletsch RH, Clay M, et al. Cardiac troponin measurement in the critically ill: potential for guiding clinical management. J Investig Med. 2015;63(8):905–15.PubMedPubMedCentral Poe S, Vandivier-Pletsch RH, Clay M, et al. Cardiac troponin measurement in the critically ill: potential for guiding clinical management. J Investig Med. 2015;63(8):905–15.PubMedPubMedCentral
28.
go back to reference Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–35.CrossRefPubMed Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–35.CrossRefPubMed
29.
go back to reference Devereaux PJCM, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295.CrossRefPubMed Devereaux PJCM, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295.CrossRefPubMed
Metadata
Title
Association between troponin-I levels and outcome in critically ill patients admitted to non-cardiac intensive care unit with high prevalence of cardiovascular risk factors
Authors
Abdulaleem Alatassi
Mohamad Habbal
Hani Tamim
Musharaf Sadat
Eman Al Qasim
Yaseen M. Arabi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2018
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-018-0515-7

Other articles of this Issue 1/2018

BMC Anesthesiology 1/2018 Go to the issue